Zobrazeno 1 - 6
of 6
pro vyhledávání: '"E. Felip Falgas"'
Autor:
S. Recalde Penabad, E. Fort, S. Otero, C. Lezcano, V.L. Obadia Gil, N. Sabaté, H. Pla Juher, E. Felip Falgas, M. Margeli Vila, G. Vinas Villaro, A.M. Esteve Gomez, M. Rey, S. Pernas Simon, S. Fontanals
Publikováno v:
ESMO Open. 8:101428
Autor:
M.A. Bergamino, E. Felip Falgas, S. Checkhun, A. Ferrando Diez, B. Cirauqui Cirauqui, I. Teruel-Garcia, M. Romeo Marin, V. Quiroga, A. Pous, A. Lopez Paradis, E. Riveira-Muñoz, E. Ballana, M. Margeli Vila
Publikováno v:
ESMO Open. 8:101261
Autor:
A. Lopez Paradis, A. Pous, L. Notario Rincon, G. Cerdà Sebastià, M. Sant Albors, M.A. Bergamino, A. Ferrando Diez, I. Teruel-Garcia, M. Romeo Marin, V. Quiroga Garcia, B. Cirauqui Cirauqui, M. Margeli Vila, E. Felip Falgas
Publikováno v:
Annals of Oncology. 33:S161-S162
Autor:
O. Martinez Saez, E. Felip Falgas, M. Cappelletti, P. Tolosa, F. Brasó-Maristany, E. Sanfeliu Torres, T. Pascual, N. Chic, M. Vidal, B. Adamo, M. Munoz, I. Faull, J. Odegaard, G. Patel, R. McEwen, D. Carroll, E.M. Ciruelos, D.G. Generali, M. Margeli Vila, A. Prat
Publikováno v:
Annals of Oncology. 33:S127-S128
Autor:
C. Fina, Margarita Romeo, J J García Mosquera, J M Hernández, H. Pla, E. Carballas, C. Erasun Lecuona, M Cucurull Salamero, L. Angelats, J.M. Piulats, M.P. Barretina Ginesta, I ruel Te García, S Martinez Román, M. Gil, Beatriz Pardo, E Felip Falgas, A.J. Arroyo, Anna Esteve
Publikováno v:
Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background Among the inflammation-related biomarkers, high MLR values are associated to poorer outcomes in different cancers. We explored the prognostic role of MLR in a multicenter series of EOC patients (p). Methods We included all pathologically c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::014228ef71299f0d1ffb2863e70ffebe
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4930
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4930
Autor:
M Cucurull Salamero, M. Margeli Vila, I ruel Te García, Max Hardy-Werbin, E Felip Falgas, C. Erasun Lecuona, J J García Mosquera
Publikováno v:
Annals of Oncology. 30:v96
Background The risk of developing second primary malignancies (SPM) in patients (p) with breast cancer (BC) is higher than among the general population. Tamoxifen, chemotherapy and breast irradiation are associated with an increased risk of SPM. The